Surgical Science Sweden

Surgical Science Sweden EBIT

The EBIT of Surgical Science Sweden (SUS.ST) as of Nov 20, 2026 is 108.97 M SEK. In the previous year, EBIT was 144.32 M SEK — a change of -24.49% (lower).

EBIT

108.97 MSEK

YoY

-24.49%

Last updated:

In 2025, Surgical Science Sweden's EBIT was 108.97 M SEK, a -24.49% increase from the 144.32 M SEK EBIT recorded in the previous year.

The Surgical Science Sweden EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
189.15 M SEK
Jan 1, 2024
144.32 M SEK
Jan 1, 2025
108.97 M SEK
Jan 1, 2026 (e)
141.36 M SEK
Jan 1, 2027 (e)
195.76 M SEK
Jan 1, 2028 (e)
237.00 M SEK
Jan 1, 2029 (e)
327.83 M SEK
Jan 1, 2030 (e)
386.74 M SEK
The Surgical Science Sweden EBIT history
YEAREBITYoY
est386.74 MSEK+17.97%
est327.83 MSEK+38.33%
est237.00 MSEK+21.07%
est195.76 MSEK+38.48%
est141.36 MSEK+29.72%
108.97 MSEK-24.49%
144.32 MSEK-23.70%
189.15 MSEK+16.37%
162.54 MSEK+83.14%
88.75 MSEK+344.33%
19.97 MSEK+31.61%
15.18 MSEK-472.99%
-4.07 MSEK-6.85%
-4.37 MSEK+2,084.00%
-200,000.00SEK-111.11%
1.80 MSEK-161.09%
-2.95 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Surgical Science Sweden Revenue

Surgical Science Sweden Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
882.85 M SEK
189.15 M SEK
233.97 M SEK
Jan 1, 2024
884.09 M SEK
144.32 M SEK
131.65 M SEK
Jan 1, 2025
992.34 M SEK
108.97 M SEK
66.82 M SEK
Jan 1, 2026 (e)
1.03 B SEK
141.36 M SEK
114.43 M SEK
Jan 1, 2027 (e)
1.14 B SEK
195.76 M SEK
159.07 M SEK
Jan 1, 2028 (e)
1.28 B SEK
237.00 M SEK
194.94 M SEK
Jan 1, 2029 (e)
1.49 B SEK
327.83 M SEK
276.70 M SEK
Jan 1, 2030 (e)
1.67 B SEK
386.74 M SEK
327.08 M SEK

Surgical Science Sweden Margins

Surgical Science Sweden stock margins

The Surgical Science Sweden margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgical Science Sweden. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgical Science Sweden.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
69.42 %
21.43 %
26.50 %
Jan 1, 2024
67.63 %
16.32 %
14.89 %
Jan 1, 2025
58.14 %
10.98 %
6.73 %
Jan 1, 2026 (e)
58.14 %
13.75 %
11.13 %
Jan 1, 2027 (e)
58.14 %
17.11 %
13.91 %
Jan 1, 2028 (e)
58.14 %
18.49 %
15.21 %
Jan 1, 2029 (e)
58.14 %
22.04 %
18.60 %
Jan 1, 2030 (e)
58.14 %
23.20 %
19.62 %

Surgical Science Sweden Stock analysis

What does Surgical Science Sweden do? Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Surgical Science Sweden's EBIT

Surgical Science Sweden's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Surgical Science Sweden's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Surgical Science Sweden's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Surgical Science Sweden’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Surgical Science Sweden stock

EBIT of Surgical Science Sweden is 108.97 M SEK in 2025.

EBIT of Surgical Science Sweden changed from 144.32 M SEK to 108.97 M SEK, representing a -24.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Surgical Science Sweden since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Surgical Science Sweden historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Surgical Science Sweden

All Key Metrics — Surgical Science Sweden